Product Information

AZITHROMYCIN 200 MG/5 ML SUSP is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.3019 per ML under NDC 70710145802. Its NADAC has been published 420 times since Nov 7, 2018.

FDA first approved this application on Jul 31, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AZITHROMYCIN 200 MG/5 ML SUSP

Azithromycin
$0.3019per ML

Strength

200 mg/5mL

NDC

70710145802

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

AZITHROMYCIN DIHYDRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA211147

FDA Approved

7/31/2018

TE Code

AB

On Market Since

8/6/2018

Pharmacological Classes

Price Statistics

The NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has been published 420 times since Nov 7, 2018, and over the history we have for it it has declined 59.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3019 per ML
All-time high$0.7499 (Nov 14, 2018)
All-time low$0.2722 (Nov 20, 2024)
52-week high$0.3301
52-week low$0.2854
Median price$0.4433
Average price$0.4644
Largest weekly change-26.0% (Jul 17, 2024)
Weeks tracked420
Tracking sinceNov 7, 2018

Price History

1W

+3.9%

1M

+5.8%

3M

+1.3%

6M

-7.0%

1Y

-10.0%

3Y

-24.9%

5Y

-40.6%

All

-59.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AZITHROMYCIN 200 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN 200 MG/5 ML SUSP, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.3019 per ML (NDC 70710145802), effective Nov 18, 2026.

How has the price of AZITHROMYCIN 200 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has declined 59.7%. It has been tracked across 420 weekly CMS publications since Nov 7, 2018.

What are the highest and lowest recorded NADAC prices for AZITHROMYCIN 200 MG/5 ML SUSP?

Since Nov 7, 2018, the NADAC for AZITHROMYCIN 200 MG/5 ML SUSP has ranged from a low of $0.2722 (Nov 20, 2024) to a high of $0.7499 (Nov 14, 2018), with a median of $0.4433 per ML.

Are there cheaper alternatives to AZITHROMYCIN 200 MG/5 ML SUSP?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AZITHROMYCIN 200 MG/5 ML SUSP, is $0.2058 per ML — about 32% below AZITHROMYCIN 200 MG/5 ML SUSP.

Who manufactures AZITHROMYCIN 200 MG/5 ML SUSP?

AZITHROMYCIN 200 MG/5 ML SUSP (NDC 70710145802) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.